Ignite Creation Date:
2025-12-24 @ 11:36 PM
Ignite Modification Date:
2026-02-25 @ 4:57 PM
Study NCT ID:
NCT03222856
Status:
COMPLETED
Last Update Posted:
2025-06-05
First Post:
2017-07-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ph II Study of Pembrolizumab & Eribulin in Patients With HR+/HER2- MBC Previously Treated With Anthracyclines & Taxanes
Sponsor:
MedSIR
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MedOPP127
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None